Atom | Breakthrough T1D Request for Applications: Supportive Technologies for the Scaling of Manufactured Islet Replacement Therapies

Due Dates: May 28, 2025 (Letter of Intent) | July 16, 2025 (Full proposal)

Funding Amounts: Up to $600,000 total for 2 years (SRA); similar scale for industry, with specific terms

Summary: Supports development of innovative technologies to scale manufactured islet cell therapies for type 1 diabetes.

Key Information: Open to both academic and industry applicants; LOI required before full proposal.

Breakthrough T1D Request for Applications: Supportive Technologies for the Scaling of Manufactured Islet Replacement Therapies